US Stock MarketDetailed Quotes

GDTC CytoMed Therapeutics

Watchlist
  • 2.100
  • -0.100-4.55%
Close Apr 26 16:00 ET
24.23MMarket Cap-7984P/E (TTM)

About CytoMed Therapeutics Company

CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.

Company Profile

SymbolGDTC
Company NameCytoMed Therapeutics
Listing DateApr 14, 2023
Issue Price4.00
Founded2018
MarketNASDAQ
Employees28
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1 Commonwealth Lane,No. 08-22, One Commonwealth
CitySingapore
ProvinceCentral Singapore
CountrySingapore
Zip Code149544
Phone65-6250-7738
Websitehttp://www.cytomed.sg

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Wee Kiat Tan, PhD
  • Co-Chief Executive Officer, Chief Operating Officer and Director
  • 88.13K
  • Dr. Jieming Zeng, M.D.
  • Chief Scientific and Medical Officer and Director
  • 89.74K
  • Yvonne Goh
  • Chief Financial Officer
  • --
  • Yoong Ying Tan
  • Chief Corporate Officer
  • --
  • Dr. Tien Wee Lucas, M.D.
  • Chief Clinical Officer and Director
  • --
  • Chee Kong Choo
  • Chairman of the Board
  • 27.32K
  • Dr. Chak Hua Yew, M.D.
  • Independent Director
  • --
  • Dr. Keng Kiat Toh, M.D.
  • Independent Director
  • --
  • Professor Yuin Han Loh, PhD
  • Independent Director
  • --
  • Thomas Tao Wu
  • Independent Director
  • --
  • Kei Wei Mark Leong
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg